NovoCure Ltd — Director's Dealing 2019

Nov 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-11-15

Reporting Person: GROENHUYSEN WILHELMUS CM (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-15	Ordinary Shares	M	20000	$3.44	Acquired	107179	Direct
2019-11-15	Ordinary Shares	S	6100	$82.531	Disposed	101079	Direct
2019-11-15	Ordinary Shares	S	12461	$83.522	Disposed	88618	Direct
2019-11-15	Ordinary Shares	S	1439	$84.007	Disposed	87179	Direct
2019-11-18	Ordinary Shares	M	5832	$3.44	Acquired	93011	Direct
2019-11-18	Ordinary Shares	S	1800	$85.352	Disposed	91211	Direct
2019-11-18	Ordinary Shares	S	3132	$86.08	Disposed	88079	Direct
2019-11-18	Ordinary Shares	S	900	$86.927	Disposed	87179	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-15	Options to Buy Ordinary Shares	$3.44	M	20000	Disposed	2021-12-13	Ordinary Shares (20000.0)	Direct
2019-11-18	Options to Buy Ordinary Shares	$3.44	M	5832	Disposed	2021-12-13	Ordinary Shares (5832.0)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen.

F2: On November 15, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 6,100 shares in multiple trades at prices ranging from $81.98 to $82.97. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: On November 15, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 12,461 shares in multiple trades at prices ranging from $82.98 to $83.98. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F4: On November 15, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 1,439 shares in multiple trades at prices ranging from $83.98 to $84.03. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F5: On November 18, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 1,800 shares in multiple trades at prices ranging from $84.65 to $85.61. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F6: On November 18, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 3,132 shares in multiple trades at prices ranging from $85.65 to $86.63. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F7: On November 18, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 900 shares in multiple trades at prices ranging from $86.66 to $87.64. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F8: Options exercised were fully vested as of the date hereof.